Global Joint Pain Injections Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Joint Pain Injections Market is presumed to reach the market size of nearly USD 12.7 Billion by 2032 from USD 6.12 Billion in 2023 with a CAGR of 8.44% under the study period 2024-2032.

Joint Pain Injections are minimally invasive treatments used to relieve pain and inflammation in joints, commonly caused by arthritis, injuries, or degenerative conditions. These injections may contain corticosteroids, hyaluronic acid, or regenerative medicine components like platelet-rich plasma (PRP). Corticosteroid injections reduce inflammation, while hyaluronic acid improves joint lubrication and cushioning. PRP and other regenerative therapies promote natural healing and tissue repair. Administered directly into the affected joint, these injections provide targeted relief and can delay the need for surgery. They are widely used in orthopedics to enhance mobility and improve the quality of life for patients with chronic joint pain.

Market Dynamics

The Joint Pain Injections market is being driven by the increasing prevalence of musculoskeletal disorders and an aging population that is more susceptible to joint-related issues. Osteoarthritis and rheumatoid arthritis cases are on the rise, boosting the demand for effective pain management solutions like Joint Pain Injections. The growing preference for minimally invasive treatments is another key factor, as Joint Pain Injections offer relief without the need for surgery. Advances in injection therapies, such as the development of platelet-rich plasma (PRP) and hyaluronic acid injections, are enhancing the efficacy and safety of Joint Pain Injections. Sports injuries are also contributing to market growth, with athletes and active individuals seeking quick and effective pain relief. The increasing awareness of joint health and the availability of advanced healthcare facilities are supporting the adoption of Joint Pain Injections. Moreover, research and development efforts to create longer-lasting and more targeted injections are driving innovation in the field. Insurance coverage and reimbursement policies for Joint Pain Injections are also positively impacting the market. The increasing availability of non-invasive treatments and safety concerns associated with repeated injections may challenge market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Joint Pain Injections. The growth and trends of Joint Pain Injections industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Joint Pain Injections market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Joint Type

Knee & Ankle
Hip Joint
Shoulder & Elbow
Facet Joints of Spine
Others

By Injection Type

Corticosteroid Injections
Hyaluronic Acid Injections
Others

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Joint Pain Injections market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Joint Pain Injections market include Allergan Plc, Pfizer Inc., Sanofi, Anika Therapeutics Inc., Ferring B.V., Bioventus, Flexion Therapeutics Inc., Zimmer Biomet Holdings Inc., Seikagaku Corporation, Chugai Pharmaceutical Co. Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11210961

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. JOINT PAIN INJECTIONS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Joint Type
- 3.7.2 Market Attractiveness Analysis By Injection Type
- 3.7.3 Market Attractiveness Analysis By Distribution Channel
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL JOINT PAIN INJECTIONS MARKET ANALYSIS BY JOINT TYPE

5.1. Overview By Joint Type
5.2. Historical and Forecast Data Analysis By Joint Type
5.3. Knee & Ankle Historic and Forecast Sales By Regions
5.4. Hip Joint Historic and Forecast Sales By Regions
5.5. Shoulder & Elbow Historic and Forecast Sales By Regions
5.6. Facet Joints of Spine Historic and Forecast Sales By Regions
5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL JOINT PAIN INJECTIONS MARKET ANALYSIS BY INJECTION TYPE

6.1. Overview By Injection Type
6.2. Historical and Forecast Data Analysis By Injection Type
6.3. Corticosteroid Injections Historic and Forecast Sales By Regions
6.4. Hyaluronic Acid Injections Historic and Forecast Sales By Regions
6.5. Others Historic and Forecast Sales By Regions

7. GLOBAL JOINT PAIN INJECTIONS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

7.1. Overview By Distribution Channel
7.2. Historical and Forecast Data Analysis By Distribution Channel
7.3. Hospital Pharmacies Historic and Forecast Sales By Regions
7.4. Retail Pharmacies Historic and Forecast Sales By Regions
7.5. Online Pharmacies Historic and Forecast Sales By Regions

8. GLOBAL JOINT PAIN INJECTIONS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE JOINT PAIN INJECTIONS COMPANIES

9.1. Joint Pain Injections Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF JOINT PAIN INJECTIONS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Allergan Plc
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Pfizer Inc.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Sanofi
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Anika Therapeutics Inc.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Ferring B.V.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Bioventus
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Flexion Therapeutics Inc.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Zimmer Biomet Holdings Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Seikagaku Corporation
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Chugai Pharmaceutical Co. Ltd
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies